Ligand Pharmaceuticals (LGND) Gross Margin (2010 - 2019)
Ligand Pharmaceuticals' Gross Margin came in at 87.31% for Q3 2019, down 9.49 percentage points from 96.80% a year earlier and down 3.06 percentage points from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Gross Margin (2010 - 2019) Analysis & Trends
Over the trailing twelve months to Sep 30, 2019, Ligand Pharmaceuticals reported Gross Margin of 91.91%, down 6.05 percentage points year-over-year; for FY2018, it came in at 97.48%, up 1.28 percentage points from FY2017.
- Gross Margin has increased in each of the last four years, with a five-year change of +9.18 percentage points (FY2013 to FY2018).
- Going back by year, Gross Margin was 96.20% in FY2017 (+1.31 pp), 94.89% in FY2016 (+2.96 pp), 91.93% in FY2015 (+6.08 pp) and 85.84% in FY2014 (-2.45 pp).
- The Q3 2019 figure represents the lowest quarterly Gross Margin since Q2 2015.
- Year-over-year, Gross Margin has declined for four consecutive quarters, with an average year-over-year change of -2.72 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q4 2015 (a gain of 13.23 percentage points), and the weakest in Q3 2019 (a drop of 9.49 percentage points).
- Business Quant data shows LGND's Gross Margin at 90.37% (Q2 2019), 91.13% (Q1 2019) and 95.04% (Q4 2018) in the three quarters before Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 87.31% |
| Jun 30, 2019 | 90.37% |
| Mar 31, 2019 | 91.13% |
| Dec 31, 2018 | 95.04% |
| Sep 30, 2018 | 96.80% |
| Jun 30, 2018 | 98.74% |
| Mar 31, 2018 | 98.60% |
| Dec 31, 2017 | 97.08% |
| Sep 30, 2017 | 94.78% |
| Jun 30, 2017 | 99.00% |
| Mar 31, 2017 | 99.39% |
| Dec 31, 2016 | 92.41% |
| Sep 30, 2016 | 95.38% |
| Jun 30, 2016 | 96.31% |
| Mar 31, 2016 | 96.78% |
| Dec 31, 2015 | 95.83% |
| Sep 30, 2015 | 92.94% |
| Jun 30, 2015 | 85.88% |
| Mar 31, 2015 | 92.64% |
| Dec 31, 2014 | 82.59% |
API Access
Ligand Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();